Latest HTA activities by Scottish Health Technology Group

15

Oct 2021

The Scottish Health Technologies Group (SHTG) is a national health technology assessment (HTA) agency providing advice to NHSScotland on the use of new and existing health technologies (excluding medicines), likely to have a significant impact on healthcare. NHSScotland is required to consider SHTG advice.

In the third quarter of 2021, SHTG published only one report in relation to HeartFlow FFRCT for estimating fractional flow reserve from coronary CT angiography. The SHTG recommendation is based on guidance produced by the National Institute for Health and Care Excellence (NICE) in 2017. The following key recommendations for NHSScotland were provided in the SHTG report:

  • HeartFlow FFRCT is non-invasive, safe and, by improving specificity, may improve the diagnosis of obstructive versus nonobstructive coronary artery disease following computerized tomography-coronary angiography (CT-CA);
  • HeartFlow FFRCT may be considered as an option alongside a set of complementary diagnostic tools for patients with stable, recent onset chest pain symptoms who have undergone CT-CA with adequate image quality on a 64-slice (or above) CT scanner;
  • The use of Heartflow FFRCT has the potential to lead to cost savings, primarily driven by a reduction in referrals for invasive coronary angiography. There is uncertainty about the level of cost savings achievable due to variations in clinical practice when investigating chest pain and the use of different patient management strategies.

SHTG is working on the following assessments related to medical procedures or technologies (as of October 6, 2021):

  • Closed-loop systems and the artificial pancreas for type I diabetes mellitus (T1DM)
  • vCreate® (asynchronous platform)
  • Dxcover ™ Brain Cancer Liquid Biopsy
  • The SARUS (safer - airway - resuscitation) - CPR hood™
  • The Scottish asynchronous digital dermatology appointment service (DDAS)
  • Living Donor Transplantation
  • Elective surgery using mesh to repair primary or incisional hernias in adults

See the full details in English here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.

The latest related news

26

Jan 2023

The updated German Uniform Evaluation Standard (EBM) catalog came into force on January 1, 2023. The EBM catalog (Einheitlicher Bewertungsmaßstab) regulates the reimbursement of services in the public outpatient sector in Germany and is updated once a quarter (four times a year). Among other changes, a new code for "zanadio" health app for follow-up and evaluation was introduced in the catalog.

Read more

25

Jan 2023

On December 31, 2022, the Decree defining the reimbursement of medical telemonitoring activities via the new framework was published in the Official Journal of the French Republic. The Decree determines the methods of evaluation of digital solutions, registration for reimbursement, modification of the registration conditions, removal and invoicing of medical telemonitoring activities, as well as the conditions for setting the reimbursement packages.

Read more

24

Jan 2023

In December 2022, NHS England launched a consultation on the preliminary 2023/25 NHS Payment Scheme, which is set for two years and will replace the National Tariff Payment System from April 2023. Two new cardiovascular categories (antibacterial envelope, mitral valve repair and replacement devices) are proposed for inclusion in the 2023/24 High Cost Device List (will be updated and reissued for 2024/25). The deadline for comments submission is January 27, 2023.

Read more

23

Jan 2023

On December 26, 2022, three more health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by sickness funds.

Read more

20

Jan 2023

In December 2022, the National Institute for Health and Care Research (NIHR) in England released six MedTech-related reports in its Health Technology Assessment (HTA) Journal, which concerned laser therapy in diabetic macular oedema, EarlyCDT Lung blood test, video-assisted thoracoscopic or open lobectomy, urethral slings for stress urinary incontinence, placental growth factor (PlGF) and sFlt-1 tests, and photobiomodulation in the management of oral mucositis. HTA Journal publishes research reports on the effectiveness, costs, and broader impact of health technologies for those who use, manage, and provide care in the NHS and informs National Institute for Health and Care Excellence (NICE) guidance.

Read more